Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

Building Diverse Careers in Clinical and Translational Research: Evaluation of a Certificate Program in Translational Research.

Comeau DL, Alvarez JA, Bhatti P, Paulsen DF, Quarshie A, Escoffery C, Ofotukun I, Eisen H, Ziegler TR, Blumberg HM.

J Clin Transl Sci. 2018 Feb;2(1):38-47. doi: 10.1017/cts.2018.19. Epub 2018 Jul 6.

2.

High-resolution plasma metabolomics analysis to detect Mycobacterium tuberculosis-associated metabolites that distinguish active pulmonary tuberculosis in humans.

Collins JM, Walker DI, Jones DP, Tukvadze N, Liu KH, Tran VT, Uppal K, Frediani JK, Easley KA, Shenvi N, Khadka M, Ortlund EA, Kempker RR, Blumberg HM, Ziegler TR.

PLoS One. 2018 Oct 11;13(10):e0205398. doi: 10.1371/journal.pone.0205398. eCollection 2018.

3.

Global Health and the Infectious Diseases Physician-Scientist Workforce.

Kempker RR, Blumberg HM.

J Infect Dis. 2019 Feb 23;219(6):1007-1008. doi: 10.1093/infdis/jiy593. No abstract available.

PMID:
30299486
4.

A population-based tuberculosis contact investigation in the country of Georgia.

Baliashvili D, Kempker RR, Blumberg HM, Kuchukhidze G, Merabishvili T, Aslanikashvili A, Magee MJ.

Public Health Action. 2018 Sep 21;8(3):110-117. doi: 10.5588/pha.18.0024.

5.

Treatment Complexities Among Patients with Tuberculosis in a High HIV Prevalence Cohort in the United States.

Bizune DJ, Kempker RR, Kagei M, Yamin A, Mohamed O, Holland DP, Oladele A, Wang YF, Rebolledo PA, Blumberg HM, Ray SM, Schechter MC.

AIDS Res Hum Retroviruses. 2018 Sep 11. doi: 10.1089/AID.2018.0126. [Epub ahead of print]

PMID:
30105915
6.

Mentoring in Global Health: Formative Evaluation of Tuberculosis Research Training Programs in Ethiopia and Georgia.

Comeau DL, Mishkin K, Tukvadze N, Avaliani Z, Kempker RR, Sthreshley L, Magee MJ, Eisen H, Mariam DH, Aseffa A, Blumberg HM.

Am J Trop Med Hyg. 2018 Sep;99(3):565-577. doi: 10.4269/ajtmh.17-0746. Epub 2018 Jul 12.

PMID:
30014815
7.

High utility of active tuberculosis case finding in an Ethiopian prison.

Merid Y, Woldeamanuel Y, Abebe M, Datiko DG, Hailu T, Habtamu G, Assefa G, Kempker RR, Blumberg HM, Aseffa A.

Int J Tuberc Lung Dis. 2018 May 1;22(5):524-529. doi: 10.5588/ijtld.17.0635.

PMID:
29663957
8.

False-Positive Tuberculin Skin Test Results Among Low-Risk Healthcare Workers Following Implementation of Fifty-Dose Vials of Purified Protein Derivative.

Collins JM, Hunter M, Gordon W, Kempker RR, Blumberg HM, Ray SM.

Infect Control Hosp Epidemiol. 2018 Jun;39(6):750-752. doi: 10.1017/ice.2018.59. Epub 2018 Apr 2.

PMID:
29606170
9.

A High Throughput Whole Blood Assay for Analysis of Multiple Antigen-Specific T Cell Responses in Human Mycobacterium tuberculosis Infection.

Whatney WE, Gandhi NR, Lindestam Arlehamn CS, Nizam A, Wu H, Quezada MJ, Campbell A, Allana S, Kabongo MM, Khayumbi J, Muchiri B, Ongalo J, Tonui J, Sasser LE, Fergus TJ, Ouma GS, Ouma SG, Beck AA, Mulligan MJ, Oladele A, Kaushal D, Cain KP, Waller L, Blumberg HM, Altman JD, Ernst JD, Rengarajan J, Day CL; TBRU-ASTRa Study Group.

J Immunol. 2018 Apr 15;200(8):3008-3019. doi: 10.4049/jimmunol.1701737. Epub 2018 Mar 14.

PMID:
29540577
10.

Tuberculosis Mortality in the United States: Epidemiology and Prevention Opportunities.

Beavers SF, Pascopella L, Davidow AL, Mangan JM, Hirsch-Moverman YR, Golub JE, Blumberg HM, Webb RM, Royce RA, Buskin SE, Leonard MK, Weinfurter PC, Belknap RW, Hughes SE, Warkentin JV, Welbel SF, Miller TL, Kundipati SR, Lauzardo M, Barry PM, Katz DJ, Garrett DO, Graviss EA, Flood JM; Tuberculosis Epidemiologic Studies Consortium.

Ann Am Thorac Soc. 2018 Feb 28. doi: 10.1513/AnnalsATS.201705-405OC. [Epub ahead of print]

PMID:
29490150
11.

A comparison of linezolid lung tissue concentrations among patients with drug-resistant tuberculosis.

Kempker RR, Heinrichs MT, Nikolaishvili K, Sabulua I, Bablishvili N, Gogishvili S, Avaliani Z, Little BP, Bernheim A, Derendorf H, Blumberg HM, Vashakidze S, Peloquin CA.

Eur Respir J. 2018 Feb 7;51(2). pii: 1702166. doi: 10.1183/13993003.02166-2017. Print 2018 Feb. No abstract available.

12.

The Impact of a Fogarty International Center-Supported Tuberculosis Research Training Program in the Country of Georgia.

Kempker RR, Tukvadze N, Sthreshley L, Sharling L, Comeau DL, Magee MJ, Del Rio C, Avaliani Z, Blumberg HM.

Am J Trop Med Hyg. 2018 Apr;98(4):1069-1074. doi: 10.4269/ajtmh.17-0667. Epub 2018 Feb 1.

PMID:
29405100
13.

Cost-effectiveness of WHO-Recommended Algorithms for TB Case Finding at Ethiopian HIV Clinics.

Adelman MW, McFarland DA, Tsegaye M, Aseffa A, Kempker RR, Blumberg HM.

Open Forum Infect Dis. 2017 Dec 23;5(1):ofx269. doi: 10.1093/ofid/ofx269. eCollection 2018 Jan.

14.

Moxifloxacin target site concentrations in patients with pulmonary TB utilizing microdialysis: a clinical pharmacokinetic study.

Heinrichs MT, Vashakidze S, Nikolaishvili K, Sabulua I, Tukvadze N, Bablishvili N, Gogishvili S, Little BP, Bernheim A, Guarner J, Peloquin CA, Blumberg HM, Derendorf H, Kempker RR.

J Antimicrob Chemother. 2018 Feb 1;73(2):477-483. doi: 10.1093/jac/dkx421.

15.

Reply to Srivastava et al., "pH Conditions under Which Pyrazinamide Works in Humans".

Kempker RR, Peloquin CA, Blumberg HM, Vashakidze S.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e01120-17. doi: 10.1128/AAC.01120-17. Print 2017 Sep. No abstract available.

16.

Smoking behavior and beliefs about the impact of smoking on anti-tuberculosis treatment among health care workers.

Magee MJ, Darchia L, Kipiani M, Chakhaia T, Kempker RR, Tukvadze N, Berg CJ, Blumberg HM.

Int J Tuberc Lung Dis. 2017 Sep 1;21(9):1049-1055. doi: 10.5588/ijtld.17.0023. Epub 2017 Jun 29.

17.

Impact of gyrB and eis Mutations in Improving Detection of Second-Line-Drug Resistance among Mycobacterium tuberculosis Isolates from Georgia.

Bablishvili N, Tukvadze N, Shashkina E, Mathema B, Gandhi NR, Blumberg HM, Kempker RR.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e01921-16. doi: 10.1128/AAC.01921-16. Print 2017 Sep.

18.

Musculoskeletal Tuberculosis.

Leonard MK, Blumberg HM.

Microbiol Spectr. 2017 Apr;5(2). doi: 10.1128/microbiolspec.TNMI7-0046-2017. Review.

PMID:
28409551
19.

Lung Tissue Concentrations of Pyrazinamide among Patients with Drug-Resistant Pulmonary Tuberculosis.

Kempker RR, Heinrichs MT, Nikolaishvili K, Sabulua I, Bablishvili N, Gogishvili S, Avaliani Z, Tukvadze N, Little B, Bernheim A, Read TD, Guarner J, Derendorf H, Peloquin CA, Blumberg HM, Vashakidze S.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e00226-17. doi: 10.1128/AAC.00226-17. Print 2017 Jun.

20.

pncA Gene Mutations Associated with Pyrazinamide Resistance in Drug-Resistant Tuberculosis, South Africa and Georgia.

Allana S, Shashkina E, Mathema B, Bablishvili N, Tukvadze N, Shah NS, Kempker RR, Blumberg HM, Moodley P, Mlisana K, Brust JC, Gandhi NR.

Emerg Infect Dis. 2017 Mar;23(3):491-495. doi: 10.3201/eid2303.161034.

21.

The Effects of First-Line Anti-Tuberculosis Drugs on the Actions of Vitamin D in Human Macrophages.

Chesdachai S, Zughaier SM, Hao L, Kempker RR, Blumberg HM, Ziegler TR, Tangpricha V.

J Clin Transl Endocrinol. 2016 Dec;6:23-29. doi: 10.1016/j.jcte.2016.08.005.

22.

Student and faculty perceptions on the rapid scale-up of medical students in Ethiopia.

Mengistu BS, Vins H, Kelly CM, McGee DR, Spicer JO, Derbew M, Bekele A, Mariam DH, Del Rio C, Blumberg HM, Comeau DL.

BMC Med Educ. 2017 Jan 13;17(1):11. doi: 10.1186/s12909-016-0849-0.

23.

The Challenge of Latent TB Infection.

Blumberg HM, Ernst JD.

JAMA. 2016 Sep 6;316(9):931-3. doi: 10.1001/jama.2016.11021. No abstract available.

24.

Improving clinical and translational research training: a qualitative evaluation of the Atlanta Clinical and Translational Science Institute KL2-mentored research scholars program.

Comeau DL, Escoffery C, Freedman A, Ziegler TR, Blumberg HM.

J Investig Med. 2017 Jan;65(1):23-31. doi: 10.1136/jim-2016-000143. Epub 2016 Sep 2.

25.

Point-of-Care Testing for Cryptococcal Disease Among Hospitalized Human Immunodeficiency Virus-Infected Adults in Ethiopia.

Mamuye AT, Bornstein E, Temesgen O, Blumberg HM, Kempker RR.

Am J Trop Med Hyg. 2016 Oct 5;95(4):786-792. Epub 2016 Aug 15.

26.

Diabetes Reduces the Rate of Sputum Culture Conversion in Patients With Newly Diagnosed Multidrug-Resistant Tuberculosis.

Salindri AD, Kipiani M, Kempker RR, Gandhi NR, Darchia L, Tukvadze N, Blumberg HM, Magee MJ.

Open Forum Infect Dis. 2016 Jun 16;3(3):ofw126. doi: 10.1093/ofid/ofw126. eCollection 2016 Sep.

27.

Metabolomics and Mycobacterial Disease: Don't Forget the Bioinformatics.

Collins JM, Kempker RR, Ziegler TR, Blumberg HM, Jones DP.

Ann Am Thorac Soc. 2016 Jan;13(1):141-2. doi: 10.1513/AnnalsATS.201510-676LE. No abstract available.

28.

Contacts of retreatment tuberculosis cases with a prior poor treatment outcome are at increased risk of latent tuberculosis infection.

Baliashvili D, Magee MJ, Kempker RR, Kuchukhidze G, Aslanikashvili A, Blumberg HM.

Int J Infect Dis. 2016 Feb;43:49-50. doi: 10.1016/j.ijid.2015.12.015. Epub 2015 Dec 25.

29.

Increased risk of latent tuberculous infection among persons with pre-diabetes and diabetes mellitus.

Hensel RL, Kempker RR, Tapia J, Oladele A, Blumberg HM, Magee MJ.

Int J Tuberc Lung Dis. 2016 Jan;20(1):71-8. doi: 10.5588/ijtld.15.0457.

30.

Efficacy and Safety of Glutamine-supplemented Parenteral Nutrition in Surgical ICU Patients: An American Multicenter Randomized Controlled Trial.

Ziegler TR, May AK, Hebbar G, Easley KA, Griffith DP, Dave N, Collier BR, Cotsonis GA, Hao L, Leong T, Manatunga AK, Rosenberg ES, Jones DP, Martin GS, Jensen GL, Sax HC, Kudsk KA, Galloway JR, Blumberg HM, Evans ME, Wischmeyer PE.

Ann Surg. 2016 Apr;263(4):646-55. doi: 10.1097/SLA.0000000000001487.

31.

Intensified tuberculosis case finding among HIV-infected persons using a WHO symptom screen and Xpert(®) MTB/RIF.

Adelman MW, Tsegaye M, Kempker RR, Alebachew T, Haile K, Tesfaye A, Aseffa A, Blumberg HM.

Int J Tuberc Lung Dis. 2015 Oct;19(10):1197-203. doi: 10.5588/ijtld.15.0230.

32.

High-dose vitamin D3 in adults with pulmonary tuberculosis: a double-blind randomized controlled trial.

Tukvadze N, Sanikidze E, Kipiani M, Hebbar G, Easley KA, Shenvi N, Kempker RR, Frediani JK, Mirtskhulava V, Alvarez JA, Lomtadze N, Vashakidze L, Hao L, Del Rio C, Tangpricha V, Blumberg HM, Ziegler TR.

Am J Clin Nutr. 2015 Nov;102(5):1059-69. doi: 10.3945/ajcn.115.113886. Epub 2015 Sep 23.

33.

Risk factors associated with loss to follow-up among multidrug-resistant tuberculosis patients in Georgia.

Kuchukhidze G, Kumar AM, de Colombani P, Khogali M, Nanava U, Blumberg HM, Kempker RR.

Public Health Action. 2014 Oct 21;4(Suppl 2):S41-6. doi: 10.5588/pha.14.0048.

34.

Increase in Lymphadenitis Cases after Shift in BCG Vaccine Strain.

Kuchukhidze G, Kasradze A, Dolakidze T, Baliashvili D, Merabishvili T, Blumberg HM, Kempker RR.

Emerg Infect Dis. 2015 Sep;21(9):1677-9. doi: 10.3201/2109.150289. No abstract available.

35.

Knowledge, attitudes, and practices regarding cervical cancer and screening among Ethiopian health care workers.

Kress CM, Sharling L, Owen-Smith AA, Desalegn D, Blumberg HM, Goedken J.

Int J Womens Health. 2015 Jul 31;7:765-72. doi: 10.2147/IJWH.S85138. eCollection 2015.

36.

Tobacco smoking and tuberculosis treatment outcomes: a prospective cohort study in Georgia.

Gegia M, Magee MJ, Kempker RR, Kalandadze I, Chakhaia T, Golub JE, Blumberg HM.

Bull World Health Organ. 2015 Jun 1;93(6):390-9. doi: 10.2471/BLT.14.147439. Epub 2015 Mar 30.

37.

Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis.

Kempker RR, Kipiani M, Mirtskhulava V, Tukvadze N, Magee MJ, Blumberg HM.

Emerg Infect Dis. 2015 Jun;21(6):992-1001. doi: 10.3201/eid2106.141873.

38.

Diabetes mellitus is associated with cavities, smear grade, and multidrug-resistant tuberculosis in Georgia.

Magee MJ, Kempker RR, Kipiani M, Gandhi NR, Darchia L, Tukvadze N, Howards PP, Narayan KM, Blumberg HM.

Int J Tuberc Lung Dis. 2015 Jun;19(6):685-92. doi: 10.5588/ijtld.14.0811.

39.

A comparison of the Xpert(®) MTB/RIF and GenoType(®) MTBDRplus assays in Georgia.

Bablishvili N, Tukvadze N, Avaliani Z, Blumberg HM, Kempker RR.

Int J Tuberc Lung Dis. 2015 Jun;19(6):676-8. doi: 10.5588/ijtld.14.0867.

40.

Cavitary penetration of levofloxacin among patients with multidrug-resistant tuberculosis.

Kempker RR, Barth AB, Vashakidze S, Nikolaishvili K, Sabulua I, Tukvadze N, Bablishvili N, Gogishvili S, Singh RS, Guarner J, Derendorf H, Peloquin CA, Blumberg HM.

Antimicrob Agents Chemother. 2015;59(6):3149-55. doi: 10.1128/AAC.00379-15. Epub 2015 Mar 16.

41.

Macronutrient intake and body composition changes during anti-tuberculosis therapy in adults.

Frediani JK, Sanikidze E, Kipiani M, Tukvadze N, Hebbar G, Ramakrishnan U, Jones DP, Easley KA, Shenvi N, Kempker RR, Tangpricha V, Blumberg HM, Ziegler TR.

Clin Nutr. 2016 Feb;35(1):205-12. doi: 10.1016/j.clnu.2015.02.007. Epub 2015 Feb 26.

42.

Disseminated emm Type 12 Group A Streptococcus and Review of Invasive Disease.

Heeke AL, Blumberg HM, Perry JM, Weiss DS, Crispell EK, Satola SW, Salinas JL.

Am J Med Sci. 2015 Nov;350(5):429-31. doi: 10.1097/MAJ.0000000000000400.

PMID:
25723882
43.

Determinants of tuberculosis infection control-related behaviors among healthcare workers in the country of Georgia.

Mirtskhulava V, Whitaker JA, Kipiani M, Harris DA, Tabagari N, Owen-Smith AA, Kempker RR, Blumberg HM.

Infect Control Hosp Epidemiol. 2015 May;36(5):522-8. doi: 10.1017/ice.2015.5. Epub 2015 Feb 4.

44.

Latent tuberculous infection in the United States and Canada: who completes treatment and why?

Hirsch-Moverman Y, Shrestha-Kuwahara R, Bethel J, Blumberg HM, Venkatappa TK, Horsburgh CR, Colson PW; Tuberculosis Epidemiologic Studies Consortium (TBESC).

Int J Tuberc Lung Dis. 2015 Jan;19(1):31-8. doi: 10.5588/ijtld.14.0373.

45.

High utility of contact investigation for latent and active tuberculosis case detection among the contacts: a retrospective cohort study in Tbilisi, Georgia, 2010-2011.

Chakhaia T, Magee MJ, Kempker RR, Gegia M, Goginashvili L, Nanava U, Blumberg HM.

PLoS One. 2014 Nov 7;9(11):e111773. doi: 10.1371/journal.pone.0111773. eCollection 2014.

46.

Plasma metabolomics in human pulmonary tuberculosis disease: a pilot study.

Frediani JK, Jones DP, Tukvadze N, Uppal K, Sanikidze E, Kipiani M, Tran VT, Hebbar G, Walker DI, Kempker RR, Kurani SS, Colas RA, Dalli J, Tangpricha V, Serhan CN, Blumberg HM, Ziegler TR.

PLoS One. 2014 Oct 15;9(10):e108854. doi: 10.1371/journal.pone.0108854. eCollection 2014.

47.

Interferon-γ release assays for the evaluation of tuberculosis infection.

Blumberg HM, Kempker RR.

JAMA. 2014 Oct 8;312(14):1460-1. doi: 10.1001/jama.2014.4928. No abstract available.

48.

Significant clinical impact of a rapid molecular diagnostic test (Genotype MTBDRplus assay) to detect multidrug-resistant tuberculosis.

Kipiani M, Mirtskhulava V, Tukvadze N, Magee M, Blumberg HM, Kempker RR.

Clin Infect Dis. 2014 Dec 1;59(11):1559-66. doi: 10.1093/cid/ciu631. Epub 2014 Aug 4.

49.

Cost analysis of a nucleic acid amplification test in the diagnosis of pulmonary tuberculosis at an urban hospital with a high prevalence of TB/HIV.

Adelman MW, Kurbatova E, Wang YF, Leonard MK, White N, McFarland DA, Blumberg HM.

PLoS One. 2014 Jul 11;9(7):e100649. doi: 10.1371/journal.pone.0100649. eCollection 2014.

50.

Active tuberculosis case finding and detection of drug resistance among HIV-infected patients: A cross-sectional study in a TB endemic area, Gondar, Northwest Ethiopia.

Alemayehu M, Gelaw B, Abate E, Wassie L, Belyhun Y, Bekele S, Kempker RR, Blumberg HM, Aseffa A.

Int J Mycobacteriol. 2014 Jun;3(2):132-8. doi: 10.1016/j.ijmyco.2014.02.004. Epub 2014 Mar 24.

Supplemental Content

Loading ...
Support Center